GRAM Stock Crashes 99.47% on May 6, 2026 as Gold Flora Faces Severe Decline

Gold Flora Corporation’s GRAM stock has experienced a catastrophic collapse, plummeting 99.47% to just $0.000001 USD on May 6, 2026. Trading on the OTC Pink Markets (PNK), the cannabis cultivation and retail company now carries a market capitalization of only $288. This represents one of the most severe declines in recent market history. The company, which went public in September 2020, faces mounting financial challenges including negative earnings, deteriorating cash flow, and a Meyka AI rating of “C” with a “Sell” recommendation. Investors should understand the critical factors driving this unprecedented collapse.

GRAM Stock Price Collapse and Market Sentiment

The GRAM stock price has reached penny stock territory after losing virtually all shareholder value. Trading volume remains extremely thin at just 200 shares on May 6, compared to an average of 17 shares daily. The stock’s year-to-date performance shows a staggering -99.99737% decline, with the 52-week high of $0.038 now a distant memory.

Market sentiment surrounding GRAM stock has turned decisively negative. The company’s current price represents a 99.47% single-day drop from the previous close of $0.000189. Technical indicators paint a bleak picture, with the Relative Strength Index (RSI) at 46.41, suggesting oversold conditions. The Money Flow Index (MFI) sits at 94.97, indicating extreme overbought pressure despite the price collapse. These contradictory signals reflect the stock’s illiquidity and distressed trading patterns.

Financial Deterioration and Key Metrics

Gold Flora’s financial position has deteriorated dramatically across all major metrics. The company reports a negative earnings per share (EPS) of -$0.42, with no meaningful price-to-earnings ratio available due to losses. The enterprise value stands at $142.6 million, creating an absurd valuation disconnect given the $288 market cap.

Operating performance reveals severe cash flow problems. Operating cash flow per share is -$0.1655, while free cash flow per share is -$0.1748, indicating the company burns cash rather than generates it. The current ratio of 0.60 falls well below the healthy threshold of 1.0, suggesting liquidity stress. Working capital is deeply negative at -$34.9 million, and tangible asset value is -$53.3 million. These metrics confirm Gold Flora faces existential financial challenges that threaten its continued operations.

Meyka AI Rating and Analyst Consensus

Meyka AI rates GRAM with a grade of B based on a total score of 65.10, with a “HOLD” suggestion. However, this rating masks severe underlying concerns. The grade factors in S&P 500 benchmark comparison (11%), sector performance (16%), industry comparison (16%), financial growth (12%), key metrics (16%), forecasts (8%), analyst consensus (14%), and fundamental growth (7%). These grades are not guaranteed and we are not financial advisors.

The company’s internal ratings reveal deep problems. The DCF score is 1 with a “Strong Sell” recommendation, while ROA scores 1 with “Strong Sell” guidance. Debt-to-equity metrics score 1 with “Strong Sell” signals. Only the ROE metric scores 5 with “Strong Buy,” but this reflects accounting anomalies rather than operational strength. The consensus recommendation is clearly “Sell,” reflecting widespread concern about Gold Flora’s viability.

Cannabis Industry Challenges and Operational Status

Gold Flora operates in the cannabis cultivation, manufacturing, extraction, distribution, and retail sectors across California. The company employs 389 full-time workers and maintains headquarters in Costa Mesa, California. However, the cannabis industry faces significant regulatory headwinds and market saturation that have pressured valuations across the sector.

The company’s earnings announcement is scheduled for May 13, 2026, which may provide clarity on recent operational performance. Track GRAM on Meyka for real-time updates and detailed financial analysis. With shares outstanding at 287.67 million, the per-share metrics reflect massive dilution. The company’s inability to generate positive cash flow or profitability suggests fundamental business model challenges beyond typical industry cyclicality.

Final Thoughts

Gold Flora’s GRAM stock collapsed 99.47% to $0.000001, reflecting severe financial distress and negative cash flows. With a market cap of $288 and deeply negative working capital, the company faces potential delisting. Strong sell signals and fundamental deterioration suggest extreme risk of total capital loss. Investors should avoid penny stocks at these levels unless prepared for complete loss.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.